,0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,308,309,310,311,312,313,314,315,316,317,318,319,320,321,322,323,324,325,326,327,328,329,330,331,332,333,334,335,336,337,338,339,340,341,342,343,344,345,346,347,348,349,350,351,352,353,354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387,388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,430,431,432,433,434,435,436,437,438,439,440,441,442,443,444,445,446,447,448,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466,467,468,469,470,471,472,473,474,475,476,477,478,479,480,481,482,483,484,485,486,487,488,489,490,491,492,493,494,495,496,497,498,499,500,501,502,503,504,505,506,507,508,509,510,511,512,513,514,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,530,531,532,533,534,535,536,537,538,539,540,541,542,543,544,545,546,547,548,549,550,551,552,553,554,555,556,557,558,559,560,561,562,563,564,565,566,567,568,569,570,571,572,573,574,575,576,577,578,579,580,581,582,583,584,585,586,587,588,589,590,591,592,593,594,595,596,597,598,599,600,601,602,603,604,605,606,607,608,609,610,611,612,613,614,615,616,617,618,619,620,621,622,623,624,625,626,627,628,629,630,631,632,633,634,635,636,637,638,639,640,641,642,643,644,645,646,647,648,649,650,651,652,653,654,655,656,657,658,659,660,661,662,663,664,665,666,667,668,669,670,671,672,673,674,675,676,677,678,679,680,681,682,683,684,685,686,687,688,689,690,691,692,693,694,695,696,697,698,699,700,701,702,703,704,705,706,707,708,709,710,711,712,713,714,715,716,717,718,719,720,721,722,723,724,725,726,727,728,729,730,731,732,733,734,735,736,737,738,739,740,741,742,743,744,745,746,747,748,749,750,751,752,753,754,755,756,757,758,759,760,761,762,763,764,765,766,767,768,769,770,771,772,773,774,775,776,777,778,779,780,781,782,783,784,785,786,787,788,789,790,791,792,793,794,795,796,797,798,799,800,801,802,803,804,805,806,807,808,809,810,811,812,813,814,815,816,817,818,819,820,821,822,823,824,825,826,827,828,829,830,831,832,833,834,835,836,837,838,839,840,841,842,843,844,845,846,847,848,849,850,851,852,853,854,855,856,857,858,859,860,861,862,863,864,865,866,867,868,869,870,871,872,873,874,875,876,877,878,879,880,881,882,883,884,885,886,887,888,889,890,891,892,893,894,895,896,897,898,899,900,901,902,903,904,905,906,907,908,909,910,911,912,913,914,915,916,917,918,919,920,921,922,923,924,925,926,927,928,929,930,931,932,933,934,935,936,937,938,939,940,941,942,943,944,945,946,947,948,949,950,951,952,953,954,955,956,957,958,959,960,961,962,963,964,965,966,967,968,969,970,971,972,973,974,975,976,977,978,979,980,981,982,983,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079,1080,1081,1082,1083,1084,1085,1086,1087,1088,1089,1090,1091,1092,1093,1094,1095,1096,1097,1098,1099,1100,1101,1102,1103,1104,1105,1106,1107,1108,1109,1110,1111,1112,1113,1114,1115,1116,1117,1118,1119,1120,1121,1122,1123,1124,1125,1126,1127,1128,1129,1130,1131,1132,1133,1134,1135,1136,1137,1138,1139,1140,1141,1142,1143,1144,1145,1146,1147,1148,1149,1150,1151,1152,1153,1154,1155,1156,1157,1158,1159,1160,1161,1162,1163,1164,1165,1166,1167,1168,1169,1170,1171,1172,1173,1174,1175,1176,1177,1178,1179,1180,1181,1182,1183,1184,1185,1186,1187,1188,1189,1190,1191,1192,1193,1194,1195,1196,1197,1198,1199,1200,1201,1202,1203,1204,1205,1206,1207,1208,1209,1210,1211,1212,1213,1214,1215,1216,1217,1218,1219,1220,1221,1222,1223,1224,1225,1226,1227,1228,1229,1230,1231,1232,1233,1234,1235,1236,1237,1238,1239,1240,1241,1242,1243,1244,1245,1246,1247,1248,1249,1250,1251,1252,1253,1254,1255,1256,1257,1258,1259,1260,1261,1262,1263,1264,1265,1266,1267,1268,1269,1270,1271,1272,1273,1274,1275,1276,1277,1278,1279,1280,1281,1282,1283,1284,1285,1286,1287,1288,1289,1290,1291,1292,1293,1294,1295,1296,1297,1298,1299,1300,1301,1302,1303,1304,1305,1306,1307,1308,1309,1310,1311,1312,1313,1314,1315,1316,1317,1318,1319,1320,1321,1322,1323,1324,1325,1326,1327,1328,1329,1330,1331,1332,1333,1334,1335,1336,1337,1338,1339,1340,1341,1342,1343,1344,1345,1346,1347,1348,1349,1350,1351,1352,1353,1354,1355,1356,1357,1358,1359,1360,1361,1362,1363,1364,1365,1366,1367,1368,1369,1370,1371,1372,1373,1374,1375,1376,1377,1378,1379,1380,1381,1382,1383,1384,1385,1386,1387,1388,1389,1390,1391,1392,1393,1394,1395,1396,1397,1398,1399,1400,1401,1402,1403,1404,1405,1406,1407,1408,1409,1410,1411,1412,1413,1414,1415,1416,1417,1418,1419,1420,1421,1422,1423,1424,1425,1426,1427,1428,1429,1430,1431,1432,1433,1434,1435,1436,1437,1438,1439,1440,1441,1442,1443,1444,1445,1446,1447,1448,1449,1450,1451,1452,1453,1454,1455,1456,1457,1458,1459,1460,1461,1462,1463,1464,1465,1466,1467,1468,1469,1470,1471,1472,1473,1474,1475,1476,1477,1478,1479,1480,1481,1482,1483,1484,1485,1486,1487,1488,1489,1490,1491,1492,1493,1494,1495,1496,1497,1498,1499,1500,1501,1502,1503,1504,1505,1506,1507,1508,1509,1510,1511,1512,1513,1514,1515,1516,1517,1518,1519,1520,1521,1522,1523,1524,1525,1526,1527,1528,1529,1530,1531,1532,1533,1534,1535,1536,1537,1538,1539,1540,1541,1542,1543,1544,1545,1546,1547,1548,1549,1550,1551,1552,1553,1554,1555,1556,1557,1558,1559,1560,1561,1562,1563,1564,1565,1566,1567,1568,1569,1570,1571,1572,1573,1574,1575,1576,1577,1578,1579,1580,1581,1582,1583,1584,1585,1586,1587,1588,1589,1590,1591,1592,1593,1594,1595,1596,1597,1598,1599,1600,1601,1602,1603,1604,1605,1606,1607,1608,1609,1610,1611,1612,1613,1614,1615,1616,1617,1618,1619,1620,1621,1622,1623,1624,1625,1626,1627,1628,1629,1630,1631,1632,1633,1634,1635,1636,1637,1638,1639,1640,1641,1642,1643,1644,1645,1646,1647,1648,1649,1650,1651,1652,1653,1654,1655,1656,1657,1658,1659,1660,1661,1662,1663,1664,1665,1666,1667,1668,1669,1670,1671,1672,1673,1674,1675,1676,1677,1678,1679,1680,1681,1682,1683,1684,1685,1686,1687,1688,1689,1690,1691,1692,1693,1694,1695,1696,1697,1698,1699,1700,1701,1702,1703,1704,1705,1706,1707,1708,1709,1710,1711,1712,1713,1714,1715,1716,1717,1718,1719,1720,1721,1722,1723,1724,1725,1726,1727,1728,1729,1730,1731,1732,1733,1734,1735,1736,1737,1738,1739,1740,1741,1742,1743,1744,1745,1746,1747,1748,1749,1750,1751,1752,1753,1754,1755,1756,1757,1758,1759,1760,1761,1762,1763,1764,1765,1766,1767,1768,1769,1770,1771,1772,1773,1774,1775,1776,1777,1778,1779,1780,1781,1782,1783,1784,1785,1786,1787,1788,1789,1790,1791,1792,1793,1794,1795,1796,1797,1798,1799,1800,1801,1802,1803,1804,1805,1806,1807,1808,1809,1810,1811,1812,1813,1814,1815,1816,1817,1818,1819,1820,1821,1822,1823,1824,1825,1826,1827,1828,1829,1830,1831,1832,1833,1834,1835,1836,1837,1838,1839,1840,1841,1842,1843,1844,1845,1846,1847,1848,1849,1850,1851,1852,1853,1854,1855,1856,1857,1858,1859,1860,1861,1862,1863,1864,1865,1866,1867,1868,1869,1870,1871,1872,1873,1874,1875,1876,1877,1878,1879,1880,1881,1882,1883,1884,1885,1886,1887,1888,1889,1890,1891,1892,1893,1894,1895,1896,1897,1898,1899,1900,1901,1902,1903,1904,1905,1906,1907,1908,1909,1910,1911,1912,1913,1914,1915,1916,1917,1918,1919,1920,1921,1922,1923,1924,1925,1926,1927,1928,1929,1930,1931,1932,1933,1934,1935,1936,1937,1938,1939,1940,1941,1942,1943,1944,1945,1946,1947,1948,1949,1950,1951,1952,1953,1954,1955,1956,1957,1958,1959,1960,1961,1962,1963,1964,1965,1966,1967,1968,1969,1970,1971,1972,1973,1974,1975,1976,1977,1978,1979,1980,1981,1982,1983,1984,1985,1986,1987,1988,1989,1990,1991,1992,1993,1994,1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023,2024,2025,2026,2027,2028,2029,2030,2031,2032,2033,2034,2035,2036,2037,2038,2039,2040,2041,2042,2043,2044,2045,2046,2047,2048,2049,2050,2051,2052,2053,2054,2055,2056,2057,2058,2059,2060,2061,2062,2063,2064,2065,2066,2067,2068,2069,2070,2071,2072,2073,2074,2075,2076,2077,2078,2079,2080,2081,2082,2083,2084,2085,2086,2087,2088,2089,2090,2091,2092,2093,2094,2095,2096,2097,2098,2099,2100,2101,2102,2103,2104,2105,2106,2107,2108,2109,2110,2111,2112,2113,2114,2115,2116,2117,2118,2119,2120,2121,2122,2123,2124,2125,2126,2127,2128,2129,2130,2131,2132,2133,2134,2135,2136,2137,2138,2139,2140,2141,2142,2143,2144,2145,2146,2147,2148,2149,2150,2151,2152,2153,2154,2155,2156,2157,2158,2159,2160,2161,2162,2163,2164,2165,2166,2167,2168,2169,2170,2171,2172,2173,2174,2175,2176,2177,2178,2179,2180,2181,2182,2183,2184,2185,2186,2187,2188,2189,2190,2191,2192,2193,2194,2195,2196,2197,2198,2199,2200,2201,2202,2203,2204,2205,2206,2207,2208,2209,2210,2211,2212,2213,2214,2215,2216,2217,2218,2219,2220,2221,2222,2223,2224,2225,2226,2227,2228,2229,2230,2231,2232,2233,2234,2235,2236,2237,2238,2239,2240,2241,2242,2243,2244,2245,2246,2247,2248,2249,2250,2251,2252,2253,2254,2255,2256,2257,2258,2259,2260,2261,2262,2263,2264,2265,2266,2267,2268,2269,2270,2271,2272,2273,2274,2275,2276,2277,2278,2279,2280,2281,2282,2283,2284,2285,2286,2287,2288,2289,2290,2291,2292,2293,2294,2295,2296,2297,2298,2299,2300,2301,2302,2303,2304,2305,2306,2307,2308,2309,2310,2311,2312,2313,2314,2315,2316,2317,2318,2319,2320,2321,2322,2323,2324,2325,2326,2327,2328,2329,2330,2331,2332,2333,2334,2335,2336,2337,2338,2339,2340,2341,2342,2343,2344,2345,2346,2347,2348,2349,2350,2351,2352,2353,2354,2355,2356,2357,2358,2359,2360,2361,2362,2363,2364,2365,2366,2367,2368,2369,2370,2371,2372,2373,2374,2375,2376,2377,2378,2379,2380,2381,2382,2383,2384,2385,2386,2387,2388,2389,2390,2391,2392,2393,2394,2395,2396,2397,2398,2399,2400,2401,2402,2403,2404,2405,2406,2407,2408,2409,2410,2411,2412,2413,2414,2415,2416,2417,2418,2419,2420,2421,2422,2423,2424,2425,2426,2427,2428,2429,2430,2431,2432,2433,2434,2435,2436,2437,2438,2439,2440,2441,2442,2443,2444,2445,2446,2447,2448,2449,2450,2451,2452,2453,2454,2455,2456,2457,2458,2459,2460,2461,2462,2463,2464,2465,2466,2467,2468,2469,2470,2471,2472,2473,2474,2475,2476,2477,2478,2479,2480,2481,2482,2483,2484,2485,2486,2487,2488,2489,2490,2491,2492,2493,2494,2495,2496,2497,2498,2499,2500,2501,2502,2503,2504,2505,2506,2507,2508,2509,2510,2511,2512,2513,2514,2515,2516,2517,2518,2519,2520,2521,2522,2523,2524,2525,2526,2527,2528,2529,2530,2531,2532,2533,2534,2535,2536,2537,2538,2539,2540,2541,2542,2543,2544,2545,2546,2547,2548,2549,2550,2551,2552,2553,2554,2555,2556,2557,2558,2559,2560,2561,2562,2563,2564,2565,2566,2567,2568,2569,2570,2571,2572,2573,2574,2575,2576,2577,2578,2579,2580,2581,2582,2583,2584,2585,2586,2587,2588,2589,2590,2591,2592,2593,2594,2595,2596,2597,2598,2599,2600,2601,2602,2603,2604,2605,2606,2607,2608,2609,2610,2611,2612,2613,2614,2615,2616,2617,2618,2619,2620,2621,2622,2623,2624,2625,2626,2627,2628,2629,2630,2631,2632,2633,2634,2635,2636,2637,2638,2639,2640,2641,2642,2643,2644,2645,2646,2647,2648,2649,2650,2651,2652,2653,2654,2655,2656,2657,2658,2659,2660,2661,2662,2663,2664,2665,2666,2667,2668,2669,2670,2671,2672,2673,2674,2675,2676,2677,2678,2679,2680,2681,2682,2683,2684,2685,2686,2687,2688,2689,2690,2691,2692,2693,2694,2695,2696,2697,2698,2699,2700,2701,2702,2703,2704,2705,2706,2707,2708,2709,2710,2711,2712,2713,2714,2715,2716,2717,2718,2719,2720,2721,2722,2723,2724,2725,2726,2727,2728,2729,2730,2731,2732,2733,2734,2735,2736,2737,2738,2739,2740,2741,2742,2743,2744,2745,2746,2747,2748,2749,2750,2751,2752,2753,2754,2755,2756,2757,2758,2759,2760,2761,2762,2763,2764,2765,2766,2767,2768,2769,2770,2771,2772,2773,2774,2775,2776,2777,2778,2779,2780,2781,2782,2783,2784,2785,2786,2787,2788,2789,2790,2791,2792,2793,2794,2795,2796,2797,2798,2799,2800,2801,2802,2803,2804,2805,2806,2807,2808,2809,2810,2811,2812,2813,2814,2815,2816,2817,2818,2819,2820,2821,2822,2823,2824,2825,2826,2827,2828,2829,2830,2831,2832,2833,2834,2835,2836,2837,2838,2839,2840,2841,2842,2843,2844,2845,2846,2847,2848,2849,2850,2851,2852,2853,2854,2855,2856,2857,2858,2859,2860,2861,2862,2863,2864,2865,2866,2867,2868,2869,2870,2871,2872,2873,2874,2875,2876,2877,2878,2879,2880,2881,2882,2883,2884,2885,2886,2887,2888,2889,2890,2891,2892,2893,2894,2895,2896,2897,2898,2899,2900,2901,2902,2903,2904,2905,2906,2907,2908,2909,2910,2911,2912,2913,2914,2915,2916,2917,2918,2919,2920,2921,2922,2923,2924,2925,2926,2927,2928,2929,2930,2931,2932,2933,2934,2935,2936,2937,2938,2939,2940,2941,2942,2943,2944,2945,2946,2947,2948,2949,2950,2951,2952,2953,2954,2955,2956,2957,2958,2959,2960,2961,2962,2963,2964,2965,2966,2967,2968,2969,2970,2971,2972,2973,2974,2975,2976,2977,2978,2979,2980,2981,2982,2983,2984,2985,2986,2987,2988,2989,2990,2991,2992,2993,2994,2995,2996,2997,2998,2999,3000,3001,3002,3003,3004,3005,3006,3007,3008,3009,3010,3011,3012,3013,3014,3015,3016,3017,3018,3019,3020,3021,3022,3023,3024,3025,3026,3027,3028,3029,3030,3031,3032,3033,3034,3035,3036,3037,3038,3039,3040,3041,3042,3043,3044,3045,3046,3047,3048,3049,3050,3051,3052,3053,3054,3055,3056,3057,3058,3059,3060,3061,3062,3063,3064,3065,3066,3067,3068,3069,3070,3071,3072,3073,3074,3075,3076,3077,3078,3079,3080,3081,3082,3083,3084,3085,3086,3087,3088,3089,3090,3091,3092,3093,3094,3095,3096,3097,3098,3099,3100,3101,3102,3103,3104,3105,3106,3107,3108,3109,3110,3111,3112,3113,3114,3115,3116,3117,3118,3119,3120,3121,3122,3123,3124,3125,3126,3127,3128,3129,3130,3131,3132,3133,3134,3135,3136,3137,3138,3139,3140,3141,3142,3143,3144,3145,3146,3147,3148,3149,3150,3151,3152,3153,3154,3155,3156,3157,3158,3159,3160,3161,3162,3163,3164,3165,3166,3167,3168,3169,3170,3171,3172,3173,3174,3175,3176,3177,3178,3179,3180,3181,3182,3183,3184,3185,3186,3187,3188,3189,3190,3191,3192,3193,3194,3195,3196,3197,3198,3199,3200,3201,3202,3203,3204,3205,3206,3207,3208,3209,3210,3211,3212,3213,3214,3215,3216,3217,3218,3219,3220,3221,3222,3223,3224,3225,3226,3227,3228,3229,3230,3231,3232,3233,3234,3235
СЛОВО,Abstract:,Lysosomal,integral,membrane,protein-2,"(LIMP-2),",encoded,by,the,SCARB2,"gene,",is,specific,lysosomal,receptor,for,glucocerebrosidase,enzyme.,Association,between,rs6812193,and,rs68250047,of,with,PD,has,been,shown,in,genetic,"studies,",including,large,genome-wide,association,studies.,The,aim,current,study,was,to,determine,whether,rs8475,are,associated,Russia.,were,genotyped,a,total,604,patients,(65,positive,(fPD),539,negative,family,history,(sPD)),413,controls,also,17,GBA,mutations,(PD-GBA),18,asymptomatic,mutation,carriers,(GBA-Carriers).,expression,measured,real-time,PCR,CD45+,blood,cells,part,individuals,studied,groups.,No,linkage,disequilibrium,Russian,population.,Increased,risk,TT,variant,(OR,=,2.02;,p,<,0.001),found,sPD,but,not,fPD.,age,at,onset,(AAO),PD.,level,decreased,GBA-PD,GBA-Carriers,compared,(padjusted,"0.02,",padjusted,"0.003,",respectively),0.013),no,significant,difference,controls.,modified,rs8475.,In,"conclusion,",status.,modifier,AAO,do,influence,on,mRNA,could,be,independent,"status.
","Buspirone,",partial,agonist,"5-HT1aR,",due,potential,antinociceptive,properties,can,useful,abdominal,pain,treatment,IBS,patients.,Pain-related,effects,buspirone,mediated,"5-HT1aRs,",located,within,nucleus,tractus,solitarius.,5-HT1aR,involvement,transmission,NTS,unclear.,objective,our,evaluate,NTS.,Using,model,urethane-anesthetized,"rats,",two,types,pain-related,neurons,responding,noxious,colorectal,distension,(CRD),excitatory,inhibitory,sustained,patterns,evoked,activity,revealed.,Buspirone,"(1.0–4.0 mg kg−1,",iv),complex,time-,dose-depended,action,CRD-induced,neuron,responses.,inhibits,responses,inverts,dose,4.0,"buspirone,",effect,attenuates.,CRD-evoked,completely,blocked,an,intra-cerebroventricular,administration,"WAY100,635.",change,this,agonist.,supraspinal,5-HT1a,receptors,"however,",its,does,dependents,these,receptors.,We,proposed,that,involved,anti-,or,pronociceptive,"pain.
","Background
",MicroRNA,(miRNAs),participate,pathogenesis,coronary,artery,disease,"(CAD).
","Objective
",To,expressions,myocardial,serum,"miRNA-27а,","miRNA-133а,",miRNA-203,CAD,"patients.
","Method
",This,cross-sectional,observational,comprised,100,subjects,(60.9 ± 1.0 years;,67%,men).,right,atrial,"miRNA-27a,",miRNA,"-133a,",80,referred,elective,bypass,graft,surgery,(CABG),20,control,scheduled,heart,valve,analyzed,using,polymerase,chain,"reaction.
","Results
",There,correlation,SYNTAX,score,I,index,(r = 0.693;,p < .001).,Patients,≥3,lesions,had,significantly,higher,than,1–2,vessel,myocardium,(miRNA-27a:,234.62 ± 29.51,vs.,182.39 ± 19.62,relative,unit,(REU);,miRNA-133а:,127.53 ± 13.41,111.35 ± 12.31,REU;,miRNA-203:,5.25 ± 0.96,4.71 ± 0.67,р < 0.05);,same,11.41 ± 3.85,4.82 ± 1.82,8.42 ± 2.43,4.35 ± 1.23,145.71 ± 15.73,43.70 ± 9.67,р < 0.05).,decision,tree,method,established,multivessel,increased,five-fold,if,>101.00,REU,"(OR,",5.90;,95%,"CI,",2.34–9.46;,"p < .001).
","Conclusions
",Both,CABG,non-CAD,subjects.,corresponds,strongly,correlated,extent,"atherosclerosis.
",A,series,binuclear,PdII,carbene,complexes,synthesized,via,cis-[PdCl2(CNXyl)2],(1),"benzo-1,3-thiazol-2-amines",(2–6),structurally,characterized.,every,case,reaction,leads,mixture,"regioisomers,",which,able,interconvert.,regioisomerization,diaminocarbene,species,showed,it,first-order,"reaction,","is,",occurs,"intramolecularly,",Hammett,function.,Electron-withdrawing,substituents,benzothiazole,moiety,as,well,increasing,solvent,polarity,accelerate,reaction.,donor,strength,correlates,less,isomerization,rates.,Based,obtained,activation,parameters,defined,interchange/dissociative,process,type.,combined,approach,kinetic,mass,spectrometric,studies,allowed,conclusion,rate-determining,step,breaking,carbon–nitrogen,bond,fragment,"complex.
","Aims
",Type,2,diabetes,mellitus,(T2DM),ranks,top,10,causes,mortality,worldwide.,key,factor,T2DM,vascular,complications,endothelial,dysfunction.,It,characterized,vessels,motor,disruption,endothelium-derived,factors,imbalance.,morphological,molecular,heterogeneity,greatly,affects,changes,occurring,T2DM.,"Therefore,",we,conducted,comparative,bed,"T2DM.
",Main,"methods
",Male,Wistar,rats,fed,high-fat,diet,"20 weeks,",followed,single,streptozotocin,injection,(20 mg/kg).,confirmed,oral,glucose,tolerance,"test.
",Key,"findings
",dose-dependent,contraction,increase,third-order,mesenteric,arterioles,response,serotonin,phenylephrine.,These,exhibited,decrease,acetylcholine-dependent,relaxation,guanylate,cyclase,At,"time,",femoral,arteries,tendency,relaxation.,plasma,analysis,revealed,low,bioavailable,nitric,oxide,high,levels,endothelin-1,"ROS.
","Significance
","knowledge,",conjunction,features,"course,",allow,further,targeted,approaches,development,prevention,"disease.
",Lorlatinib,novel,potent,ALK,"inhibitor,",only,few,reporting,results,clinical,"use.
","Methods
",describes,outcomes,lorlatinib,35,non-small,cell,lung,cancer,"rearrangements,",who,"(n = 5),",1,(n = 26),none,(n = 4),prior,tyrosine,kinase,inhibitors,received,mainly,compassionate,use,"program.
",Objective,tumor,(OR),(DC),registered,15/35,(43%),33/35,(94%),"patients,",respectively;,brain,metastases,particularly,responsive,(OR:,22/27,(81%);,DC:,27/27,(100%)).,Median,progression,free,survival,(PFS),estimated,21.8,"months,",median,overall,(OS),approached,70.1,months.,Only,4,out,experienced,adverse,effects;,them,benefit,from,lorlatinib.,PFS,OS,no-adverse-events,users,strikingly,lower,remaining,(1.1,months,23.7,10.5,"reached,",0.0001,both,comparisons).,translocation,variants,known,28,patients;,there,statistical,V.1,V.3,rearrangements,regard,"PFS.
","Conclusion
",Use,excellent,"outcomes,",however,caution,must,taken,experiencing,"drug.
",three,bariatric,interventions,infarct,size,tested,rat,type,(T2DM).,evaluated,no-reflow,phenomenon,dysfunction,caused,Rats,assigned,into,groups:,without,"surgery,","sham-operated,",ileal,"transposition,",Roux-en-Y,gastric,"bypass,",sleeve,gastrectomy.,Oral,"tolerance,",glucagon-like,"peptide-1,",insulin,measured.,Six,weeks,after,animals,subjected,ischemia-reperfusion,histochemical,determination,"(IS),","zone,",stasis,area,size.,Vascular,wire,"myography.
",All,reductions,animal,body,weight,resulted,compensation.,partially,normalized,peptide-1,attenuated,IS,smaller,Bariatric,provided,additional,limitation,alone.,surgeries,reversed,T2DM-induced,enhanced,contractile,5-hydroxytryptamine.,Sleeve,gastrectomy,synthase,contribution,endothelium-dependent,vasodilatation,reduction,zone,infarct-limiting,"effect,",augmented,contractility,typical,"together,",suggest,may,have,beneficial,cardiovascular,"diseases.
",present,investigates,event-related,oscillations,underlying,motion-onset,(MOR),sounds,moving,different,velocities.,EEG,recorded,stationary,sound,motion,produced,interaural,time,differences.,explored,velocity,MOR,"potential,",spectral,perturbation,(ERSP),inter-trial,phase,coherence,(ITC),calculated,time-frequency,decomposition,signals.,slow,similarly,magnitude,cN1,cP2,components,response.,delta-to-alpha,power,remained,up,"to,","including,",highest,"velocity,",suggesting,gradual,spatial,did,induce,non-coherent,activity.,"Conversely,",abrupt,displacement,induced,theta-alpha,consistency.,findings,generated,resetting,"oscillations,",degree,considered,neurophysiological,indicator,"processing.
",currently,thought,full,glycogen,molecule,(β-particle),spherical,shape,12,concentric,tiers,residues,glycogenin,center,diameter,about,42,nm.,"However,",structure,β-particle,remains,poorly,understood.,"study,",β-particles,hepatocytes,starved,situ,cytofluorometry,technique,measurement,speed,staining,Schiff's,reagent.,measurements,molecules,quickly,"stained,",labile,fraction,(LF),represents,internal,"molecule,",while,slowly,stable,(SF),external,proteins.,predicts,3rd,4th,(42%,all),bound,7th,8th,together,~19%,tier,never,proteins,enzyme,amount,particle,surface,variable.,"Thus,",makes,possible,obtain,data,particular,"cell.
",Background,"Eculizumab,",terminal,complement,reduced,relapse,placebo,anti-aquaporin-4,immunoglobulin,G-positive,(AQP4+),neuromyelitis,optica,spectrum,disorder,(NMOSD),PREVENT,trial.,report,efficacy,safety,analyses,Asian,open-label,extension,(OLE).,Methods,"double-blind,","randomized,",3,AQP4+,NMOSD,randomly,(2:1),receive,intravenous,eculizumab,(maintenance,"dose,",1200 mg/2,weeks),placebo.,completed,OLE.,Analyses,performed,prespecified,subgroup,Results,Of,143,"enrolled,",52,(36.4%),included,"(eculizumab,",n = 37;,"placebo,",n = 15);,45,Most,(86.5%),concomitant,immunosuppressive,therapy.,During,"PREVENT,",one,adjudicated,occurred,receiving,six,(hazard,"ratio,",0.05;,confidence,interval:,0.01–0.35;,p = 0.0002).,An,95.2%,relapse-free,144,treatment.,Upper,respiratory,tract,"infections,","headache,",nasopharyngitis,most,common,events,subgroup.,Conclusion,Eculizumab,reduces,"NMOSD,",benefit–risk,profile,similar,benefits,maintained,during,long-term,Clinical,trial,registration,ClinicalTrials.gov,identifiers:,NCT01892345,(PREVENT);,NCT02003144,(open-label,"extension).
",task,identify,differences,synchronization,intermittent,photic,stimulation,arterial,hypertension,manifestations,moderate,cognitive,impairment,such,manifestations.,solve,used,recurrence,based,"index,",ratio,instantaneous,"frequencies,",duration,synchrosqueezed,wavelet,transform,light,series.,greater,synchronization.,manifested,photostimulation,bioelectric,"brain,",shift,frequency,range,excitation,frequency.,assessment,"origin.
",Migraine,sensitisation,trigeminovascular,system,often,accompanied,mechanical,hyperalgesia,allodynia.,mechanisms,mechanotransduction,migraine,attack,yet,unknown.,ion,channel,Piezo1,"involved,",since,expressed,trigeminal,ganglion,"neurons,","thus,",contribute,neuronal,component,system.,took,advantage,extracellular,recordings,trigeminocervical,–,relay,centre,"pathway,",directly,assess,impact,differently,applied,Yoda1,sensory,processing,spinal,level.,slightly,facilitated,ongoing,firing,central,substance,contributed,suppression,their,intravital,"microscopy,",dilation,meningeal,innervated,afferents.,"Collectively,",here,identified,modulation,selective,mechanosensitive,"channels,",provide,new,evidence,favour,role,pathogenesis.,propose,several,underlie,"Yoda1.
",Silica,silicon,"dioxide,","which,",depending,production,"method,",exist,various,amorphous,forms,varying,"area,","size,",pore,volume,"and,","result,",physicochemical,sorption,characteristics.,presence,silanol,groups,silicas,provides,possibility,functionalisation.,"addition,",developed,Aerosil,allows,composites,content,biologically,active,substances.,"work,",biocompatibility,composite,380,carboxylated,fullerene,"C60[C(COOH)2]3,",namely:,haemolysis,(spontaneous,"photoinduced),",platelet,"aggregation,",binding,"HSA,",cyto-,"genotoxicity,",antiradical,Interest,creation,nanomaterial,fact,fullerenes,applications,fields,"biomedicine,",ability,bind,reactive,oxygen,"species,",inhibition,tumour,"development,",inactivation,viruses,bacteria.,immobilisation,drugs,"theranostics.
",TNF-α,inflammatory,cytokine.,stem,regions,carotid,"bodies,",organs,monitoring,O2.,hypothesised,circulating,necrosis,(TNF)-α,affect,ventilation,modulate,hypoxic,ventilatory,cyclooxygenase,(COX),(NOS),pathways.,compare,before,pretreatment,diclofenac,L-NG-nitro,arginine,methyl,ester,(L-NAME),nonspecific,COX,"NOS,",respectively.,anaesthetised,rebreathing,techniques.,normoxia,hypoxia.,Pretreatment,each,TNF-α.,believe,NOS-related,pathways,“cross-talk”,mediates,underlies,inflammation,"function.
","ABSTRACT
",HLA-haploidentical,transplantation,(haplo-HCT),post-transplantation-cyclophosphamide,(PT-Cy),feasible,procedure,children,malignancies.,Haplo-HCT,PT-Cy,childhood,acute,lymphoblastic,leukemia,(ALL),lacking.,haplo-HCT,180,ALL.,9,"years,",follow-up,2.7,years.,Disease,status,CR1,"24%,",CR2,"45%,",CR+3,"12%,",19%.,day,+3,+4.,Bone,marrow,(BM),source,115,(64%).,Cumulative,incidence,42-day,engraftment,88.9%.,day-100,graft-versus-host,(GVHD),grade,II-IV,"28%,",2-year,chronic,GVHD,21.9%.,cumulative,nonrelapse,(NRM),19.6%.,41.9%,25%,CR1.,Estimated,"65%,","44%,",18.8%,transplanted,"CR1,","CR2,",CR3+,3%,year,disease.,multivariable,(CR2,[hazard,{HR} = 2.19;,"P = .04]),",HCT,older,13,(HR = 2.07;,P = .03),peripheral,(PBSC),(HR = 1.98;,P = .04),survival.,PBSC,NRM,(HR = 3.13;,P = .04).,option,"ALL,",namely,those,CR2.,Age,remain,important,outcomes.,BM,improved,"survival.
","Summary
",COVID-19,pandemic,having,profound,mental,health,consequences,many,people.,Concerns,"that,","extreme,",manifest,suicide,aimed,early,rates,around,"world.
",sourced,countries,areas,through,systematic,internet,search,recourse,networks,published,literature.,Between,Sept,Nov,"1,","2020,",searched,official,websites,countries’,ministries,"health,",police,"agencies,",government-run,statistics,agencies,"equivalents,",translated,terms,“suicide”,“cause,"death”,",broadening,attempt,other,public,sources.,Data,given,country,they,came,government,available,monthly,least,Jan,"2019,",July,"31,",2020.,Our,searches,restricted,more,million,residents,pragmatic,"reasons,",relaxed,rule,literature,networks.,Areas,populations,million.,interrupted,time-series,trend,suicides,(from,March,2020),"country,",comparing,expected,number,derived,observed,April,primary,"analysis).
","Findings
",21,(16,high-income,five,upper-middle-income,"countries),",whole-country,ten,11,countries).,Rate,ratios,(RRs),CIs,versus,numbers,began,any,area.,areas:,New,South,"Wales,",Australia,(RR,0·81,[95%,CI,0·72–0·91]);,"Alberta,",Canada,(0·80,[0·68–0·93]);,British,"Columbia,",(0·76,[0·66–0·87]);,Chile,(0·85,[0·78–0·94]);,"Leipzig,",Germany,(0·49,[0·32–0·74]);,Japan,(0·94,[0·91–0·96]);,Zealand,(0·79,[0·68–0·91]);,Korea,[0·92–0·97]);,"California,",USA,(0·90,[0·85–0·95]);,Illinois,(Cook,"County),",[0·67–0·93]);,Texas,(four,"counties),",(0·82,[0·68–0·98]);,Ecuador,(0·74,"[0·67–0·82]).
","Interpretation
",first,examine,context,multiple,countries.,"countries,",largely,unchanged,declined,pre-pandemic,period.,need,vigilant,poised,respond,situation,longer-term,economic,"unfold.
","Funding
","None.
",HIV-positive,people,inject,(PWID),experience,stigma,related,"HIV,",care,utilization,health.,help,affected,cope,intersectional,reduce,"care,",adapted,behavioral,coping,intervention,HIV,"population.
",conduct,randomized,controlled,(RCT),testing,‘Stigma,Coping,Reduce,risks,Improve,Prevention,Treatment’,(SCRIPT),"intervention,","community-based,",form,Acceptance,Commitment,Therapy,"(ACT),",PWID,living,St.,"Petersburg,","Russia.
",recruited,civil,society,organizations,(CSO),delivering,harm,services,participants,2:1,either,(three,ACT,sessions,group,format,over,month,usual,CSO,care),aims,psychological,flexibility,handle,stigma-related,"expectations,",emotions,experiences.,satisfaction,"scores.
",Stigma,targeting,outside,formal,settings,confront,negativities,lives,originating,stigma's,"barrier.
",Mutations,gene,(GBA),encoding,(GCase),cause,Gaucher,(GD),commonly,Parkinson,(PD).,Ambroxol,effective,pharmacological,chaperones,GCase.,Fourteen,GD,"(GBA-PD),",thirty,enrolled.,GCase,hexosylsphingosine,(HexSph),concentration,dried,macrophage,spots,liquid,chromatography,coupled,tandem,spectrometry.,ambroxol,lysosomes,assessed,confocal,microscopy.,cultured,macrophages,patient,monocytic,(PBMC),(by,3.3-fold),3.5-fold),untreated,(p < 0.0001,"p < 0.0001,",four,days,cultivation.,HexSph,2.1-fold),1.6-fold),respectively).,colocalization,marker,LAMP2.,modes,mutant,carrying,N370S,amino,acid,substitution,pH,4.7,examined,docking,dynamics,simulations.,position,minimal,energy,close,vicinity,"residue,",370.,Taken,PBMC-derived,assessing,therapy,Rationale,&,Hemodialysis,(HD),kidney,replacement,"use,","availability,","accessibility,","affordability,",quality,HD,"worldwide.
",Study,"Design
","survey.
",Setting,"Participants
",Stakeholders,"(clinicians,",policy,"makers,",consumer,representatives),182,convened,International,Society,Nephrology,"September 2018.
","Outcomes
","Use,","care.
",Analytical,"Approach
",Descriptive,"statistics.
","Overall,",representatives,160,(88%),participated.,country-specific,maintenance,298.4,"(IQR,",80.5-599.4),per,population,(pmp).,Global,among,incident,failure,98.0,81.5-140.8),pmp,centers,4.5,1.2–9.9),pmp.,Adequate,(3-4,hours,times,weekly),generally,27%,low-income,Home,36%,32%,patient-reported,outcomes;,"61%, monitoring",small-solute,clearance;,"60%, monitoring",bone,mineral,markers;,"51%, monitoring",survival;,"60%,",initiation,"dialysis,",5%,arteriovenous,access,almost,all,education,"suboptimal,",funding,procedures,"uniform,",copayments,income.,23%,pay,>75%,costs,4%,"countries.
","Limitations
",survey,"bias,",social,desirability,limited,collection,preventing,in-depth,"analysis.
","summary,",reveal,substantial,variations,global,"quality,",affordability,"worldwide,",lowest,evident,low-,lower-middle–income,prognosis,refractory,induction,chemotherapy,immunotherapy,dismal.,Salvage,allogeneic,hematopoietic,(HSCT),widely,10%,15%,cured,procedure.,Preclinical,indicate,post-transplantation,cyclophosphamide,bendamustine,(PTB),prophylaxis,regimen,graft-versus-leukemia,(GVL),establish,optimal,PTB,antileukemic,HSCT,prophylaxis.,prospective,"(NCT02799147),",administered,doses,"140,","100,",70,mg/m2,Myeloablative,conditioning,fludarabine,busulfan,single-agent,"PTB,",subsequent,combination,tacrolimus,mycophenolate,mofetil,(MMF).,Inclusion,criteria,myelogenous,(AML),course,target,≥5%,clonal,blasts,marrow.,cohort,22,AML,5,Seven,enrolled,140,(due,stopping,"rule),",Primary,documented,41%,secondary,59%.,blast,count,start,18%,"(range,",6%,97%).,Transplantation,matched,sibling,mismatched,unrelated,"15,",haploidentical,7.,Engraftment,93%,89%,complete,remission,63%,measurable,residual,After,"prophylaxis,",unusual,"complication,",cytokine,release,syndrome,"(CRS),",70%,CRS,44%.,frequent,symptoms,fever,abnormal,liver,function,tests,"67%,",pancreatitis,"63%,",skin,vasculitis,"56%,",enterocolitis,"48%,",mucosa,"37%,",disseminated,intravascular,coagulation,nervous,toxicity,26%.,HLA-mismatched,(75%,20%;,P = .0043).,Classic,44%,Grade,(67%,25%;,P = .031).,Moderate,severe,100-day,survivors,immunosuppression,(100%,18%;,P = .002).,relatively,rate,Three-year,28%,(95%,interval,"[CI],",13%,"46%),",event-free,29%,46%).,Nonrelapse,46%,"64%),",26%,11%,44%).,relapses,+100.,statistically,(P = .3481);,mg/kg,group.,Survival,ALL,(35%,0%;,P = .0157).,promising,augment,GVL,AML;,CRS-associated,necessitates,complication.,routine,application,cannot,recommended.,Combination,MMF,ameliorates,"complications,",setting,HLA-matched,allografts.,Biological,require,"elucidation.
",Previous,diagnosed,schizophrenia,(SCZ),deficits,visual,"processing,",contrast,processing.,brain-derived,neurotropic,(BDNF),measure,investigate,neuroplasticity,some,functions,like,perception.,investigated,relationship,BDNF,first-episode,SCZ,Thirty-nine,healthy,43,Contrast,sensitivity,"low,",mid-,frequencies.,First-episode,except,middle,Negative,correlations,"BDNF,","variables,",mostly,frequencies,females.,support,(i),alterations,magno-,parvocellular,pathway,functioning,(ii),highlights,importance,biomarkers,along,measures,"disorders.
","Purpose
",analyze,5-year,biochemical,disease-free,(bDFS),late,prostate,treated,pencil,beam,scanning,(PBS),proton,radiation,"therapy.
","Materials
",January,2013,"2016,",284,intensity,modulated,"(IMPT),",ultrahypofractionated,schedule,(36.25,GyE,fractions).,Five,immediately,lost,thus,excluded,analysis.,279,prospectively,collected,56.5,3.4-87.5),mean,64.5,(40.1-85.7),prostate-specific,antigen,(PSA),value,6.35,μg/L,(0.67-17.3,μg/L).,121,(43.4%),"low-risk,",125,(44.8%),"favorable,",33,(11.8%),unfavorable,intermediate-risk,cancer.,49,(17.6%),underwent,neoadjuvant,hormonal,"therapy,",adjuvant,bDFS,profiles,"evaluated.
",7-18,days).,"96.9%,","91.7%,",83.5%,"low-,","group,",Late,(Common,Terminology,Criteria,Adverse,Events,v.4),follows:,gastrointestinal:,62,"(22%),","2,","(7.2%),","3,",(0.36%);,genitourinary:,"(28.7%),",14,"(5%),",0,PSA,"(6.1%),",lymph,node,detected,Four,(1.4%),local,recurrences,detected.,Nine,(3.2%),died,deaths,"reported.
",Ultrahypofractionated,comparable,fractionation,schedules,serious,GI,GU,"toxicity.
",Cajal-Retzius,transient,elements,developing,cerebral,cortex.,express,characteristic,molecules.,One,"them,",heavy-chain,"neurofilaments,",participating,construction,mature,"networks,",believed,feature,human’s,cells.,stain,SMI-32,antibody,non-phosphorylated,horizontally,oriented,soma,bipolar,processes,labeled,layer,cortex,cats,aged,0–2,postnatal,days.,DiI,"technique,",well-developed,parallel,vertical,branches,coming,horizontal,visualized,areas.,location,general,morphology,allowing,suppose,carnivores,share,primates,developmental,"corticogenesis.
",recent,"decades,",semiconductor,lasers,successfully,rhinology.,usage,nasal,swell,(NSB),barely,studied.,research,experimental,selection,laser,exposure,mode,NSB,970 nm,diode,safe,reduction.,thermometric,wavelength,continuous,contact,2 W,10 W,step.,"cattle,",optical,region.,experiments,temperature,"data,",4 W.,demonstrate,causing,thermal,damage,adjacent,tissue.,"experiment,",improve,breathing,hypertrophy,39,vasomotor,rhinitis,NSB.,divided,Group,consisted,laser-turbinectomy,laser.,19,pathology,"laser-turbinectomy,",dynamic,observation,respiration,according,anterior,rhinomanometry,when,subgroups,t-criterion,samples,(p > 0.05).,As,result,NOSE,scale,Student's,"t-test,",(p < 0.001).,perform,subjectively,noted,insufficiency,breathing.,indicates,regulation,"airflow.
",Trace,amine-associated,(TAARs),class,G,protein-coupled,detect,biogenic,"amines,",products,decarboxylation,acids.,majority,TAARs,(TAAR2-TAAR9),described,olfactory,epithelium,sensing,innate,odors.,members,"family,","TAAR5,",limbic,projection,emotions.,mouse,line,lacking,TAAR5,(TAAR5,"knockout,",TAAR5-KO,mice),beta-galactosidase,mapping,expression.,mice,dopamine,striatal,"metabolites,",GDNF,"mRNA,",elevated,indicating,proliferation.,"Furthermore,",major,neurogenic,subventricular,"(SVZ),",subgranular,(SGZ),potentially,surrounding,ventricle.,Direct,neurogenesis,markers,doublecortin,(DCX),proliferating,nuclear,(PCNA),2-fold,SVZ,SGZ,"mice,",observations,emotional,adult,transmission.,future,antagonists,exert,antidepressant,and/or,anxiolytic,opportunity,neurodegenerative,disorders,Parkinson's,hemispheric,asymmetry,ERPs,low-frequency,oscillatory,hemispheres,stimuli,delayed,motion.,Event-related,computed,read,books,choice,(passive,listening),indicated,trajectories,perceived,graphic,tablet,(active,listening).,goal,find,lateralization,consistent,right-hemispheric,"dominance,",contralateral,neglect,interhemispheric,asymmetry.,Apparent,dominance,hemisphere,ERSP,Stronger,contralaterality,left,corresponding,“neglect,model”,delta-alpha,oscillations.,Velocity,attention,consistently,how,pattern,interrelated,motion-related,single-trial,"measures.
",Antibodies,aquaporin-4,(AQP4),water,reported,trigger,"cascade,",implicated,astrocyte,injury.,demonstrated,inhibitor,anti-AQP4,NMOSD.,reducing,across,clinically,relevant,"PREVENT.
","time-to-event,","trial,",adults,1200 mg/2 weeks),"(2:1),",stable-dose,(IST),permitted,(except,rituximab,mitoxantrone).,Post,hoc,post,IST,demographic,"characteristics,",autoimmune,"comorbidity.
",previous,"age,","sex,","region,","race,",historical,annualized,"rate,",baseline,Expanded,Disability,Status,Scale,"score,",another,disorder.,infection,regardless,"year,","disorder.
",Across,wide,"risk,",apparent,"rate.
",Trial,"registration
","(ClinicalTrials.gov).
",Carboxylated,"fullerenes,","particular,",tris-malonate,C60,"(C60[C(COOH)2]3,","CF),",great,interest,studying,"plants,",primarily,"malonate,",biological,"activity,",means,improving,crop,yield,quality.,Impact,water-soluble,derivatives,physiological,plant,state,enough.,paper,devoted,C60[C(COOH)2]3,"state,",growth,netto,productivity,"salad,","tomatoes,",spring,"barley,",wheat,initial,stages,seed,germination,vegetative,period,plants,following,reasons:,absorption,assimilation,capacity,roots,aerial,parts,plants;,moisture,substances,organs;,entering,distributing,"organs,",containing,physiologically,organic,"compounds,",cyclic,catabolism;,optimising,antioxidant,shows,indicators,seedling,"condition,",solutions,CCF = 0.001–0.1,mg·dm−3,test,"plants.
",Approximately,worldwide,peritoneal,dialysis,practice,"globe.
","clinicians,","delivery,",outcome,Responses,88%,(n=160),313,(257,nephrologists,"[82%],",non-nephrologist,physicians,"[7%],",6,professionals,"[2%],",administrators/policy,makers/civil,servants,"[5%],",others,[4%]).,85%,(n=156),responded,questions,38.1,30,156,(19%),PD-related,"questions,",Africa,(20/41),(15/22).,69%,modality,for≤10%,newly,failure.,1%,"costs,",(>75%),(out-of-pocket,expenses,incurred,patients),Asia,Average,exchange,volumes,adequate,(defined,3-4,exchanges,equivalent,automated,PD),72%,"outcomes.
",Low,makers;,explanations,underpinning,lack,granular,data;,"data.
",Large,inter-,intraregional,disparities,"world,",greatest,gaps,"Asia.
",effectiveness,regimens,dydrogesterone,management,endometriosis-related,pelvic,"Observational,","months.
","Setting
",Twenty,gynecology,clinics,"Federation.
","Patient(s)
",Three,hundred,fifty,women,years,endometriosis,"dysmenorrhea.
","Intervention(s)
",Dydrogesterone,mg,"daily,",5th,25th,menstrual,cycle,(prolonged,cyclical,regimen),continuously,(continuous,regimen).,For,cutoff,"treatment.
",Outcome,"Measure(s)
",Intensity,11-point,numerical,rating,(after,"months).
","Result(s)
",marked,prolonged,(mean,±,standard,deviation,–3.3,2.2,–3.0,"2.2,","respectively),",With,"regimens,",improvements,"pain,",analgesics,"required,",severity,"dysmenorrhea,",sexual,"well-being,",health-related,quality-of-life,parameters.,A favorable,"confirmed,",drug,reactions,"study.
","Conclusion(s)
",Prolonged,pronounced,dysmenorrhea,led,life,"well-being.
",Registration,"Number
","NCT03690765.
",Los,regímenes,de,tratamiento,didrogesterona,cíclicos,y,continuos,prolongados,son,efectivos,para,reducir,el,dolor,pélvico,crónico,en,mujeres,con,endometriosis:,resultados,del,estudio,"ORCHIDEA.
","Objetivo
",Comparar,la,efectividad,dos,diferentes,manejo,relacionado,"endometriosis.
","Diseño
",Estudio,cohortes,prospectivo,observacional,durante,seis,"meses.
","Entorno
",Veinte,clínicas,ginecológicas,Federación,"Rusa.
","Paciente(s)
",Trescientas,cincuenta,entre,años,edad,o,sin,"dismenorrea.
","Intervención(es)
",Didrogesterona,ó,veces,al,"día,",bien,los,días,25,ciclo,menestrual,(régimen,cíclico,prolongado),ininterrumpido,continuo).,Para,todas,las,pacientes,se,limitó,recogida,datos,meses,"tratamiento.
",Medida(s),resultado,"principal(es)
",Intensidad,una,escala,puntuación,numérica,puntos,(tras,"meses).
","Resultado(s)
",Se,observó,marcada,reducción,tanto,régimen,prolongado,como,continuo,(cambio,nivel,basal,medio,desviación,estándar,"-3,3","2,2","-3,0","2,2,","respectivamente),",diferencia,significativa,ambos,grupos.,Con,"regímenes,",experimentaron,mejoras,significativas,intensidad,"crónico,",número,que,requirieron,"analgésicos,",severidad,"dismenorrea,",bienestar,parámetros,calidad,vida,relacionados,salud.,confirmó,un,perfil,seguridad,favorable,"didrogesterona,",informó,reacciones,adversas,severas,medicación,"estudio.
","Conclusión(es)
",demostraron,pronunciada,dismenorrea,resultaron,marcadas,todos,estudiados,"sexual.
",Novel,strategies,needed,optimise,surgical,resection,early-stage,non-small-cell,(NSCLC).,atezolizumab,best,supportive,platinum-based,IMpower010,"randomised,","multicentre,","open-label,",done,227,sites,regions.,Eligible,resected,stage,IB,(tumours,≥4,cm),IIIA,NSCLC,Union,Internationale,Contre,le,Cancer,American,Joint,Committee,staging,(7th,edition).,(1:1),permuted-block,(block,four),(1200,days;,16,cycles,year),(observation,regular,scans,recurrence),(one,cycles).,"endpoint,",investigator-assessed,"survival,",hierarchically,II–IIIA,whose,tumours,PD-L1,"(SP263),",then,"population,",finally,intention-to-treat,(ITT),(stage,IB–IIIA).,Safety,care.,"ClinicalTrials.gov,",NCT02486718,"(active,","recruiting).
",Oct,"7,","2015,","19,","2018,",1280,resection.,1269,"chemotherapy,",whom,1005,eligible,randomisation,(n=507),(n=498);,495,32·2,(IQR,27·4–38·3),(HR,0·66;,0·50–0·88;,p=0·0039),(0·79;,0·64–0·96;,p=0·020).,ITT,HR,(0·67–0·99;,p=0·040).,Atezolizumab-related,53,(11%),"(1%).
","NSCLC,","cells,",Atezolizumab,offers,"NSCLC.
",F,Hoffmann-La,Roche,"Genentech.
",,Genetics,"Russia,
",Buspirone-dependent,Abdominal,Pain,Transmission,Within,Nucleus,Tractus,Solitarius,"Rat,
",disease:,"study,
",Reaction,mechanism,(diaminocarbene)PdII,"complexes,
",region-specific,tone,mellitus:,Opposite,acetylcholine,"5-hydroxytryptamine,
",Efficacy,carcinomas,distinct,variants:,single-center,Effects,"mellitus,
",Brain,"motion,
",Cytochemical,"hepatocytes,
",anti-aquaporin-IgG-positive,disorder:,"extension,
",Estimation,"transform,
",Differential,system:,electrophysiological,microscopy,"rats,
",Biocompatibility,nanocomposite,"C60[C(COOH)2]3,
",Cyclooxygenase,mediate,Outcomes,Unmanipulated,Haploidentical,Post-Transplant,Cyclophosphamide,Pediatric,Acute,Lymphoblastic,"Leukemia,
",Suicide,trends,pandemic:,preliminary,"countries,
",Addressing,barrier,drugs:,Design,RCT,increases,restores,patient-derived,"Parkinsonism,
",Practice,Patterns:,Survey,"Study,
",Graft-versus-Host,Prophylaxis,Post-Transplantation,Bendamustine,Refractory,Leukemia:,Dose-Ranging,Visual,"schizophrenia,
",Proton,Radiation,Treatment,Intermediate-Risk,Prostate,Cancer-5-Year,"Outcomes,
",labeling,feline,"cortex,
","body,
",trace,(TAAR5),knockout,"mice,
",Lateralization,auditory,motion:,"analysis,
",Benefits,Subgroup,"trial,
",Plant,Peritoneal,Dialysis,ORCHIDEA,Adjuvant,IB–IIIA,(IMpower010):
ВСТРЕТИЛОСЬ_РАЗ_в_2021,31,1,1,1,1,1,1,32,382,8,1,42,5,3,2,70,4,1,2,13,7,294,1,359,140,22,4,5,6,263,3,1,7,3,1,3,1,61,3,2,25,92,124,1,2,7,19,12,2,70,1,88,2,1,83,1,3,1,1,3,1,3,1,1,5,13,3,4,3,1,4,1,1,1,1,12,3,3,1,2,9,11,1,3,6,5,4,1,1,2,4,2,10,1,1,1,4,1,2,2,1,6,1,11,20,1,5,27,3,1,2,7,6,4,2,12,2,1,1,1,2,1,17,9,5,1,2,1,17,1,1,1,1,2,2,45,1,8,19,3,1,1,1,4,1,5,5,1,3,7,1,4,10,19,1,9,1,12,5,2,1,2,8,1,1,1,2,2,3,6,1,4,3,5,1,6,7,1,1,6,4,4,11,2,1,1,1,1,4,6,1,6,4,7,1,2,1,1,3,1,1,3,1,2,3,1,11,1,4,1,1,12,1,1,2,1,24,1,1,1,3,22,1,1,1,5,4,12,1,1,12,1,21,3,31,6,1,35,1,2,6,1,1,1,2,5,5,17,1,5,6,5,8,8,2,3,7,1,3,1,10,5,1,2,4,2,1,2,1,2,2,2,3,1,2,1,1,1,2,7,1,3,4,1,1,1,4,19,1,1,1,6,3,1,1,1,1,3,1,1,8,1,2,9,5,7,8,1,1,1,2,1,8,1,1,1,1,2,1,1,5,2,1,1,1,4,1,1,1,1,1,1,1,1,1,3,1,1,9,1,3,1,1,1,1,4,4,1,1,4,1,1,1,1,1,1,1,2,1,13,2,4,1,2,2,1,3,1,1,1,1,1,1,3,1,1,1,1,1,7,1,1,3,1,1,7,5,1,1,1,1,1,1,3,1,1,1,1,22,5,2,2,1,1,2,5,1,2,3,2,2,3,4,6,3,1,1,1,1,1,1,1,2,1,6,1,1,1,1,1,1,1,1,1,2,1,10,4,2,1,1,1,4,2,4,1,4,4,7,10,2,2,1,2,5,3,1,1,1,3,1,1,4,1,1,1,8,4,4,1,14,2,1,1,3,3,2,1,1,7,3,1,1,1,2,1,1,1,1,1,3,5,1,1,2,2,1,1,9,1,3,1,12,1,1,3,1,2,2,1,1,1,4,1,2,3,1,1,1,10,5,4,1,5,5,9,9,1,1,2,1,1,2,1,1,5,2,1,4,2,2,1,2,1,4,2,8,1,4,8,8,1,5,1,5,5,2,1,6,6,7,1,9,1,7,1,1,1,2,1,1,3,11,3,1,12,1,1,1,1,1,2,1,1,1,1,9,2,8,1,2,1,1,1,1,1,1,1,4,1,4,10,1,4,1,1,9,5,1,1,1,2,1,2,2,2,7,1,3,3,28,1,1,2,1,1,1,4,1,1,8,1,1,1,1,8,1,4,2,2,1,1,3,2,1,1,1,1,1,3,4,1,1,1,1,1,2,1,1,4,5,4,4,5,2,2,5,1,3,3,1,2,2,1,4,3,1,5,2,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,2,16,2,1,1,2,1,1,1,1,3,2,3,1,1,5,1,1,2,1,3,1,2,3,1,1,2,1,3,3,3,1,2,1,2,3,1,1,1,1,1,3,2,2,2,11,5,1,1,2,1,1,2,3,10,13,1,1,1,4,2,2,4,1,2,2,2,1,3,1,5,2,1,9,6,2,2,7,2,1,2,6,1,3,2,2,3,18,5,2,1,2,2,3,2,1,1,1,1,2,1,1,4,3,1,1,1,1,1,1,1,8,4,2,1,3,1,1,1,1,1,1,3,1,1,1,3,2,1,1,1,2,1,1,8,3,1,1,1,3,1,5,5,1,1,1,2,1,1,4,5,1,1,1,1,3,1,1,2,2,2,4,1,1,1,1,1,2,3,1,2,1,2,1,3,1,1,1,1,1,1,2,3,1,3,1,1,1,2,1,1,1,1,1,1,1,3,1,2,5,2,4,1,3,2,12,1,1,1,1,2,3,3,12,6,1,2,2,2,4,4,4,2,2,10,2,1,2,5,3,10,2,1,1,2,2,2,14,5,3,3,1,4,1,14,2,4,1,1,1,1,2,1,4,2,6,1,1,2,1,1,1,5,1,1,1,1,3,2,1,5,2,4,1,2,6,2,3,4,4,1,1,1,2,1,1,1,4,1,1,1,2,1,7,1,1,1,1,7,3,4,1,1,2,2,2,1,3,7,1,2,4,3,1,4,1,1,1,2,1,1,1,1,2,2,2,5,3,2,2,3,2,1,3,3,3,4,1,1,8,3,7,1,2,1,2,2,2,2,1,3,1,2,1,1,1,1,1,1,1,3,1,2,2,1,1,1,4,6,2,1,1,1,1,4,1,3,1,1,1,1,2,5,1,3,7,2,1,3,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,2,5,1,2,4,3,4,1,1,1,1,1,1,2,5,1,1,9,2,1,1,1,1,1,1,1,2,1,1,1,1,4,3,4,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,4,1,1,1,1,2,1,1,1,1,1,1,1,2,1,2,1,1,2,1,2,2,3,1,1,1,1,5,1,1,1,2,2,6,6,1,1,1,1,1,1,1,3,1,1,1,1,1,1,1,2,1,1,1,1,2,1,1,1,1,1,5,1,1,1,1,1,3,1,6,1,1,4,1,1,1,1,4,1,1,1,1,1,1,2,1,2,3,1,1,1,1,2,3,1,1,1,1,1,1,1,1,2,1,2,1,1,1,1,1,1,6,1,1,1,2,1,1,1,2,1,2,1,2,1,1,2,1,1,3,1,2,3,1,7,2,5,2,1,1,1,2,2,3,4,1,1,2,4,3,1,1,1,1,1,1,3,2,2,1,2,1,4,1,1,3,5,1,1,1,1,2,2,11,2,1,2,10,4,1,2,1,1,1,1,3,1,1,1,1,1,2,1,2,1,1,1,2,1,1,1,1,1,1,2,1,1,1,1,1,1,1,2,1,1,1,1,4,1,2,2,1,1,2,2,1,1,2,1,2,5,7,3,1,3,8,3,1,1,1,2,1,1,6,4,5,1,2,1,2,22,5,3,1,2,3,1,1,1,1,3,2,1,5,2,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,7,1,1,2,2,4,1,1,1,4,2,5,2,2,4,3,1,6,1,1,8,3,1,1,1,1,1,1,1,1,1,1,2,2,1,5,2,2,1,1,3,5,7,2,12,1,6,1,2,3,1,4,1,2,1,1,1,4,1,1,1,1,1,9,2,1,1,2,1,2,4,1,1,1,2,1,2,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,2,1,1,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,3,2,1,1,5,2,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,3,3,2,1,1,7,3,1,11,1,1,3,2,2,3,4,1,3,1,2,2,6,1,2,4,2,1,1,1,1,1,1,1,1,1,1,2,1,2,1,1,2,1,3,2,3,3,1,1,1,1,1,1,1,1,2,3,1,3,1,2,1,3,1,2,1,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,3,1,1,2,1,2,1,1,1,2,3,5,1,1,1,1,5,1,1,2,6,1,1,3,1,2,1,1,1,1,1,1,5,1,1,1,1,1,3,6,1,1,4,1,1,1,2,2,3,5,1,1,1,1,1,1,1,1,1,2,2,1,2,1,2,1,1,2,1,1,1,2,2,1,1,1,1,1,1,1,1,8,2,4,2,1,4,1,6,5,5,4,6,9,1,2,3,2,2,2,2,1,3,2,1,1,2,2,4,2,2,2,2,1,1,2,2,2,2,1,2,1,1,1,1,2,1,3,1,4,6,1,1,3,1,2,1,1,1,1,1,1,1,1,1,1,2,1,2,1,4,1,1,1,2,1,1,1,1,1,4,1,1,1,1,1,1,1,1,1,3,1,8,1,1,1,1,1,2,1,1,2,1,1,1,2,2,1,2,1,1,2,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,5,2,7,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,2,7,1,1,1,2,1,1,1,1,1,2,4,1,2,1,1,2,1,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,2,3,2,8,1,3,1,1,1,1,1,5,1,1,1,1,1,1,1,3,1,1,2,2,1,1,2,1,1,1,1,1,1,3,1,1,1,1,3,1,1,1,1,1,1,1,1,4,1,1,1,1,1,2,2,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,4,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,2,1,1,1,1,3,1,1,4,1,1,2,1,1,1,1,1,1,1,1,2,1,2,1,3,1,1,1,1,1,1,1,1,2,1,2,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,2,1,1,1,7,1,3,1,1,1,1,2,2,1,2,1,1,1,1,1,3,4,6,1,2,1,1,3,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,2,1,5,1,2,5,3,1,2,1,1,3,2,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,2,1,1,2,2,2,1,1,3,1,2,1,10,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,2,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,2,1,1,1,4,1,1,1,4,1,1,1,2,1,2,1,1,1,1,2,2,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,5,2,1,1,1,1,1,1,6,3,4,8,4,4,1,1,2,1,4,2,2,1,1,1,1,1,1,1,1,1,2,1,2,2,1,1,1,1,1,1,1,1,1,2,1,2,1,1,1,1,1,1,1,1,1,3,1,1,1,5,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,3,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,1,6,1,1,3,1,2,1,1,2,5,2,1,1,1,1,1,1,1,1,2,1,1,1,1,2,2,2,1,3,2,1,1,2,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,2,1,3,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,2,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,3,1,1,1,1,2,2,1,1,1,1,2,1,1,1,1,1,2,1,1,1,3,3,2,2,1,1,1,1,1,1,1,1,1,1,4,1,1,2,1,3,1,1,3,1,2,1,1,1,1,1,1,1,2,1,1,1,1,1,2,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,2,2,1,1,1,1,3,1,1,1,1,1,1,1,1,1,2,1,2,1,1,1,3,1,1,2,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,2,3,1,1,1,1,1,1,1,1,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,4,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,4,4,1,1,7,1,1,1,1,1,1,1,1,1,1,1,2,2,2,1,1,1,3,1,1,1,1,1,1,4,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,6,1,1,1,1,1,1,1,2,1,2,1,1,1,2,1,3,1,1,1,1,1,1,1,1,1,1,2,2,1,1,1,1,1,1,1,2,3,26,5,3,1,12,1,2,1,1,1,1,5,7,7,6,9,2,8,2,1,6,1,1,1,1,9,1,1,1,1,1,1,1,1,1,1,1,2,2,1,1,1,1,1,1,1,1,1,1,3,1,1,2,2,1,1,1,1,1,2,1,1,3,2,1,1,1,2,3,1,1,1,1,1,2,2,3,1,1,1,1,1,1,1,1,1,3,1,1,1,1,1,1,1,2,1,1,2,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,2,1,1,1,1,1,1,1,2,1,2,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,2,1,7,6,6,2,3,2,2,2,1,1,1,1,1,4,8,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,6,3,3,3,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,2,1,1,2,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,2,2,3,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,2,1,1,1,1,1,1,1
